Virgin Money rolls out standalone cancer cover

clock

Virgin Money has unveiled a new type of limited condition critical illness insurance targeted as individuals seeking financial protection in the event of cancer.

Administered by Scottish Widows, the Virgin Cancer Cover product, also marketed as “The Big V”, is a direct offer reviewable CI product which is available from as little as £5 per month and is said to be around 45% cheaper than a standard CIC product, as it only pays out on diagnosis of cancer. Under the terms of the product, Virgin Money will make ‘staged’ payments to the sufferer of any cancer except skin cancer and early diagnosis of cervical cancer, both of which are easily treatable, but the amount paid will depend on the severity of the condition. A payment of 10% of the sum assur...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Protection

Pure protection in focus: FCA market study raises regulatory expectations for 2026

Pure protection in focus: FCA market study raises regulatory expectations for 2026

Commission models and fair value under scrutiny

Joe Norburn
clock 20 February 2026 • 6 min read
Scottish Widows adds beneficiary nomination

Scottish Widows adds beneficiary nomination

For life policies

Cameron Roberts
clock 18 February 2026 • 1 min read
Chesnara to close HSBC Life UK to new protection business

Chesnara to close HSBC Life UK to new protection business

Follows £260m acquisition

Jaskeet Briah
clock 04 February 2026 • 3 min read